Posted by Michael Wonder on 30 Sep 2025
FDA grants fast track designation for CS-1103, a first in class small molecule to reverse acute intoxication from methamphetamine
30 September 2025 - Clear Scientific announced today that the US FDA has granted its lead asset, CS-1103, fast track designation for treatment of acute methamphetamine intoxication.
CS-1103 is an injectable therapeutic that, in non-clinical studies, binds and encapsulates intoxicants in the blood, rapidly reversing their toxic effects.
